IRRIMAX CORPORATION

Irrimax Corporation is a medical device manufacturer specializing in antimicrobial wound irrigation solutions. The company's flagship product, Irrisept Antimicrobial Wound Lavage, is a self-contained jet lavage system containing 0.05% chlorhexidine gluconate (CHG) in sterile water for irrigation. Irrisept delivers low-pressure irrigation suitable for mechanical cleansing and removal of debris, dirt, and foreign materials including microorganisms from acute, surgical, and post-surgical wounds. The solution is non-cytotoxic and backed by extensive safety testing, in-vivo/in-vitro studies, and randomized controlled trial data. Available in multiple bottle sizes including standard and 150mL versions with convenience caps, Irrisept is trusted by over 4,500 U.S. hospitals across pre-hospital, acute care, and post-acute settings including outpatient clinics and skilled nursing facilities. The product is referenced in independent publications and aligned with guidelines from the American College of Surgeons and International Wound Infection Institute.